Results 101 to 110 of about 176,246 (351)
Implantation of Short-Term and Long-Term Right Ventricular Assist Devices
Brazilian Journal of Cardiovascular SurgeryThe last decade has seen considerable growth in the use of left ventricular assist devices (LVAD), in end-phase heart failure treatment. The indications, contraindications and implantation techniques are well-defined.
Christiano Castello Branco Caldeira +2 more
doaj +1 more source
Left Ventricular Assist Devices A Rapidly Evolving Alternative to Transplant [PDF]
Left ventricular assist devices are becoming an increasingly prevalent therapy for patients with Stage D heart failure with reduced ejection fraction. Technological advances have improved the durability of these devices and have significantly lengthened ...
Colombo, Paolo C., Mancini, Donna
core +1 more source
Metal–Organic Frameworks: Unlocking New Frontiers in Cardiovascular Diagnosis and Therapy
Advanced Science, EarlyView.Metal–organic frameworks (MOFs), are composed of metal ions and bridging organic ligands, are recognized as an excellent platform for host‐gust chemistry. Its rich structural composition, modifiable sites, and multilevel pore distribution can provide delivery and release of signaling molecules, probes, and therapeutic drugs, which exhibit great medical
Qilu Wu +6 more
wiley +1 more source
Microbiology SpectrumVentricular assist device (VAD) infections are frequent causes of hospital readmission. The risk factors and optimal preventive strategies for such, including chronic suppressive antibiotics (CSA), remain uncertain.
Shinya Yamamoto +14 more
doaj +1 more source
Blood Damage in Ventricular Assist Devices [PDF]
The International Journal of Artificial Organs, 2016 Advancements in both the design of mechanical circulatory support (MCS) and medical care for recipients have led to steady improvements in patient survival over the last decades. Indeed, current generations of ventricular assist devices (VADs), for example, provide important therapeutic alternatives for individuals with heart failure that may be ...
Marcus Granegger +2 more
openaire +5 more sources
Advanced Science, EarlyView.Cardiomyocyte‐enriched USP20 regulates the K63‐linked ubiquitination of STAT3, and the cardiomyocyte‐specific USP20‐STAT3‐CARM1 axis exerts a protective role in cardiac hypertrophy. Targeting USP20 through cardiac‐specific gene therapy presents a promising strategy for the treatment of cardiac hypertrophy.
Lingfeng Zhong +15 more
wiley +1 more source
Ophthalmic Surgery in Patients with Left Ventricular Assist Devices
Case Reports in Ophthalmological Medicine, 2019 The newer generation of left ventricular assist devices (LVADs) are commonly used as destination therapy; these devices have demonstrated improved outcomes and increased survival.
George A. Dumas +2 more
doaj +1 more source
Occupational Therapy’s Role with Ventricular Assist Devices and the Promotion of Travel Protocols [PDF]
, 2020 An option for individuals diagnosed with end-stage heart failure is to receive a ventricular assist device (VAD). In 2006, Shepherd and Wilding produced an article regarding occupational therapy’s role during the VAD process as they anticipated a growing
Chandra, Natasha, Suplicki, Linda
core +1 more source
Stochastic Modelling and Dynamic Analysis of Cardiovascular System with Rotary Left Ventricular Assist Devices [PDF]
Mathematical Problems in Engineering, 2018, 2018 The left ventricular assist device (LVAD) has been used for end-stage heart failure patients as a therapeutic option. The aortic valve plays a critical role in heart failure and its treatment with LVAD. The cardiovascular-LVAD model is often used to investigate the physiological demands required by patients and predict the hemodynamic of the native ...
arxiv